461 related articles for article (PubMed ID: 12383322)
1. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
[TBL] [Abstract][Full Text] [Related]
2. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
4. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
5. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
Wildemeersch D; Janssens D; Weyers S
Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
[TBL] [Abstract][Full Text] [Related]
6. Effect of hysterectomy or LNG-IUS on serum inhibin B levels and ovarian blood flow.
Halmesmäki KH; Hurskainen RA; Cacciatore B; Tiitinen A; Paavonen JA
Maturitas; 2007 Jul; 57(3):279-85. PubMed ID: 17329045
[TBL] [Abstract][Full Text] [Related]
7. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
[TBL] [Abstract][Full Text] [Related]
8. The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women.
Järvelä I; Tekay A; Jouppila P
Hum Reprod; 1998 Dec; 13(12):3379-83. PubMed ID: 9886518
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.
Nahum GG; Kaunitz AM; Rosen K; Schmelter T; Lynen R
Contraception; 2015 May; 91(5):412-7. PubMed ID: 25661510
[TBL] [Abstract][Full Text] [Related]
10. The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Machado RB; de Souza IM; Beltrame A; Bernardes CR; Morimoto MS; Santana N
Gynecol Endocrinol; 2013 May; 29(5):492-5. PubMed ID: 23461277
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.
Heliövaara-Peippo S; Hurskainen R; Teperi J; Aalto AM; Grénman S; Halmesmäki K; Jokela M; Kivelä A; Tomás E; Tuppurainen M; Paavonen J
Am J Obstet Gynecol; 2013 Dec; 209(6):535.e1-535.e14. PubMed ID: 23999423
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
Monteiro I; Bahamondes L; Diaz J; Perrotti M; Petta C
Contraception; 2002 May; 65(5):325-8. PubMed ID: 12057782
[TBL] [Abstract][Full Text] [Related]
13. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Vuorma S; Yliskoski M; Paavonen J
Acta Obstet Gynecol Scand; 2009; 88(12):1389-96. PubMed ID: 19878089
[TBL] [Abstract][Full Text] [Related]
14. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
[TBL] [Abstract][Full Text] [Related]
15. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
El Behery MM; Saleh HS; Ibrahiem MA; Kamal EM; Kassem GA; Mohamed Mel S
Reprod Sci; 2015 Mar; 22(3):329-34. PubMed ID: 25001020
[TBL] [Abstract][Full Text] [Related]
17. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Cihangir U; Ebru A; Murat E; Levent Y
Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
[TBL] [Abstract][Full Text] [Related]
20. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]